Cargando…

Review of Prevention for Pediatric and Adolescent Migraine

Authors from the Barrow Neurological Institute at Phoenix Children’s Hospital present a narrative overview of preventive treatment for pediatric and adolescent migraine.

Detalles Bibliográficos
Autores principales:	Qubty, William, Gelfand, Amy A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pediatric Neurology Briefs Publishers 2016
Materias:	Headache Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4798855/ https://www.ncbi.nlm.nih.gov/pubmed/27004139 http://dx.doi.org/10.15844/pedneurbriefs-30-1-4

Ejemplares similares

Acute Treatment Regimens for Migraine in the ED
por: Millichap, J. Gordon
Publicado: (2015)

Cyclic AMP Accumulation in Migraine Induction
por: Chelse, Ana B., et al.
Publicado: (2015)

Migraine, Celiac Disease and Intestinal Microbiota
por: Rahmoune, Hakim, et al.
Publicado: (2017)

Pediatric Intracranial Hypertension
por: Sivaswamy, Lalitha
Publicado: (2016)

Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?
por: Simioni, Caio Vinicius de Meira Grava
Publicado: (2022)

Vestibular migraine
por: Silva, Viviane Passarelli Ramin, et al.
Publicado: (2022)

Chronic migraine: Genetics or environment?
por: Chalmer, Mona Ameri, et al.
Publicado: (2021)

Acute Migraine Therapy: New Drugs and New Approaches
por: Monteith, Teshamae S., et al.
Publicado: (2010)

Cold extremities in migraine: a marker for vascular dysfunction in women
por: Linstra, K. M., et al.
Publicado: (2020)

Intracranial Hypertension in Children without Papilledema
por: Chelse, Ana B., et al.
Publicado: (2015)

Blunt Head Trauma and Headache
por: Chelse, Ana B., et al.
Publicado: (2015)

Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial
por: Ashina, Messoud, et al.
Publicado: (2021)

Functional connectivity changes in complex migraine aura: beyond the visual network
por: Silvestro, Marcello, et al.
Publicado: (2021)

It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine
por: Kubota, Gabriel Taricani
Publicado: (2022)

Multinational descriptive analysis of the real‐world burden of headache using the Migraine Buddy application
por: Goadsby, Peter J., et al.
Publicado: (2021)

Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real‐world evidence
por: Khalil, Modar, et al.
Publicado: (2022)

Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy: The multicenter prospective cohort GARLIT study
por: Vernieri, Fabrizio, et al.
Publicado: (2022)

Preventing chronicity of migraine
por: Fanciullacci, M., et al.
Publicado: (2005)

Basic Considerations for the Use of Monoclonal Antibodies in Migraine
por: Levin, Morris, et al.
Publicado: (2018)

Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials
por: Hindiyeh, Nada A., et al.
Publicado: (2019)

Visual snow syndrome, the spectrum of perceptual disorders, and migraine as a common risk factor: A narrative review
por: Klein, Antonia, et al.
Publicado: (2021)

A narrative review of the calcitonin peptide family and associated receptors as migraine targets: Calcitonin gene‐related peptide and beyond
por: Garelja, Michael L., et al.
Publicado: (2022)

Preventive non–pharmacological treatment and nitric oxide in chronic migraine
por: Ciancarelli, I., et al.
Publicado: (2005)

Behavioural intervention in medication overuse headache: A concealed double‐blind randomized controlled trial
por: Pijpers, Judith A., et al.
Publicado: (2022)

Habituation of single CO(2) laser–evoked responses during interictal phase of migraine
por: de Tommaso, M., et al.
Publicado: (2005)

Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study
por: Grosberg, Brian, et al.
Publicado: (2021)

Headache as an acute and post‐COVID‐19 symptom in COVID‐19 survivors: A meta‐analysis of the current literature
por: Fernández‐de‐las‐Peñas, César, et al.
Publicado: (2021)

Headaches and obesity
por: Fortini, Ida, et al.
Publicado: (2022)

Update on Idiopathic Intracranial Hypertension Management
por: Souza, Marcio Nattan Portes, et al.
Publicado: (2022)

Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study
por: de Vries Lentsch, Simone, et al.
Publicado: (2021)

First‐line steroid treatment for spontaneous intracranial hypotension
por: Tonello, Simone, et al.
Publicado: (2022)

Clinic and genetic predictors in response to erenumab
por: Zecca, Chiara, et al.
Publicado: (2022)

The History of the Migraine Trust
por: Rose, F. C.
Publicado: (2006)

Migraine in the emergency department: a psychometric study of a migraine “repeaters” sample
por: Villani, V., et al.
Publicado: (2005)

The Temperament and Character Inventory in women with migraine
por: Mongini, F., et al.
Publicado: (2005)

Atypical Perfusion Manifestation in Migraine with Aura
por: Lester, Jacobo, et al.
Publicado: (2021)

Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype
por: Dalla Volta, G., et al.
Publicado: (2005)

Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
por: Tso, Amy R., et al.
Publicado: (2017)

Adult Abdominal Migraine Improved by OnabotulinumtoxinA Injections
por: Hermanowicz, Neal
Publicado: (2021)

Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients
por: Sternieri, E., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_89b3u2p3pesdthg5p9nm4e44g6